Internal restructuring
Nord Ovest; Lombardia; Milano
Location of affected unit(s)
Basiglio and Caponago
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

330 jobs
Number of planned job losses
Job loss
Announcement Date
28 June 2007
Employment effect (start)
3 September 2007
Foreseen end date


The British-Swedish company AstraZeneca is one of the world leaders in producing medicines and other healthcare solutions. It has around 65,000 employees in the world and 14 manufacturing plants in 19 countries. In Italy, AstraZeneca has around 2,100 employees who work both in the commercial and administrative divisions located in Basiglio and Caponago, both in the province of Milan. At the beginning of 2007 the company announced a cost-saving plan that will affect all its plants worldwide. As part of this plan, at the end of June 2007 AstraZeneca Italia announced the loss of 330 jobs in the Italian commercial division located in Basiglio and Caponago. The company has made this decision in order to tackle the cut in profits following the latest national policy on the reduction of prices of several pharmaceutical products. In the next days, the company and the trade unions will meet in order to define measures to support the affected employees.


  • 29 June 2007: Il Sole 24 Ore


Eurofound (2007), Astra Zeneca, Internal restructuring in Italy, factsheet number 65556, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65556.